Immuneering's market cap is currently ―. The company's EPS TTM is $-1.885; its P/E ratio is -0.78; Immuneering is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $-0.50. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	$ 39.57K	$ 455.00
Gross Profit	-	-	-	$ 39.57K	$ 455.00
EBIT	$ -15.78M	$ -12.60M	$ -12.19M	$ -14.44M	$ -13.65M
EBITDA	$ -15.78M	-	$ -12.00M	$ -14.43M	$ -13.64M
Net Income Common Stockholders	$ -15.08M	$ -12.60M	$ -12.19M	$ -13.60M	$ -13.13M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 85.67M	$ 97.24M	$ 108.99M	$ 91.54M	$ 105.52M
Total Assets	$ 102.58M	$ 113.88M	$ 124.90M	$ 107.70M	$ 122.37M
Total Debt	$ 4.46M	$ 4.54M	$ 4.64M	$ 4.74M	$ 4.84M
Net Debt	$ -81.20M	$ -92.70M	$ -104.34M	$ -86.79M	$ -100.68M
Total Liabilities	$ 12.01M	$ 9.86M	$ 9.79M	$ 9.91M	$ 122.37M
Stockholders Equity	$ 90.58M	$ 104.02M	$ 115.10M	$ 97.79M	$ 109.85M
Cash Flow	-
Free Cash Flow	$ -11.95M	-	$ -10.84M	$ -14.45M	$ -11.82M
Operating Cash Flow	$ -11.78M	$ -12.03M	$ -10.75M	$ -14.42M	$ -11.75M
Investing Cash Flow	$ 3.13M	$ -23.97M	$ 9.16M	$ 18.97M	$ 8.15M
Financing Cash Flow	$ 7.83K	$ 21.45K	$ 28.17M	$ 239.41K	$ -184.68K

Currency in USD

Immuneering Earnings and Revenue History

Income Statement >

Immuneering Debt to Assets

Balance Sheet >

Immuneering Cash Flow

Cash Flow >

Immuneering Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing